Entrada Therapeutics, Inc. - stock earnings
TRDA Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 8, 2024 BeforeMarket | - / -0.3800000000 | - | - / 15.0 million | - |
TRDA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 35.5 million USD | 43.7 million USD |
| 2023Q2 | -25.9 million USD | 18.2 million USD |
| 2023Q1 | -6.7 million USD | 25.3 million USD |
| 2022Q4 | -22.2 million USD | ? USD |
| 2022Q3 | -23.5 million USD | ? USD |
| 2022Q2 | -22.4 million USD | ? USD |
| 2022Q1 | -20.7 million USD | ? USD |
| 2021Q4 | -18.4 million USD | ? USD |
| 2021Q3 | -14.4 million USD | ? USD |
| 2021Q2 | -9.9 million USD | ? USD |
| 2021Q1 | -8.4 million USD | ? USD |
| 2020Q4 | -8.7 million USD | ? USD |
| 2020Q3 | -7.0 million USD | ? USD |
TRDA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.8 million USD | 87.2 million USD |
| 2022 | -87.5 million USD | 25.3 million USD |
| 2021 | -50.1 million USD | ? USD |
| 2020 | -26.4 million USD | ? USD |
| 2019 | -4.6 million USD | ? USD |
TRDA
Price: $13.48
52 week price:
Earnings Per Share: -0.20 USD
P/E Ratio: -21.03
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 22900
Market Capitalization: 445.6 million